After more than 20 years of strong growth in net profits, Sagicor Group Jamaica is reporting a 12 percent decline. But it’s not all bad news. We’ll speak about Sagicor’s latest results and their plans for 2021 with President and CEO, Christopher Zacca.
And later, THE ANALYSTS weigh in on the latest market developments…. Indies Pharma has continued to record steady growth in its first quarter ended January 31 2021. And The LAB’s revenue is up nearly 40-percent for its first quarter. We’ll discuss.
